BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 31721598)

  • 1. Intrinsic properties of medical devices: considerations for economic evaluation.
    Basu R; Eggington S
    Expert Rev Pharmacoecon Outcomes Res; 2019 Dec; 19(6):619-626. PubMed ID: 31721598
    [No Abstract]   [Full Text] [Related]  

  • 2. Improving the Methods for the Economic Evaluation of Medical Devices.
    Tarricone R; Callea G; Ogorevc M; Prevolnik Rupel V
    Health Econ; 2017 Feb; 26 Suppl 1():70-92. PubMed ID: 28139085
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Challenges in the Assessment of Medical Devices: The MedtecHTA Project.
    Tarricone R; Torbica A; Drummond M
    Health Econ; 2017 Feb; 26 Suppl 1():5-12. PubMed ID: 28139084
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Key Recommendations from the MedtecHTA Project.
    Tarricone R; Torbica A; Drummond M;
    Health Econ; 2017 Feb; 26 Suppl 1():145-152. PubMed ID: 28139086
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MEDICAL DEVICE PRICES IN ECONOMIC EVALUATIONS.
    Akpinar I; Jacobs P; Husereau D
    Int J Technol Assess Health Care; 2015 Jan; 31(1-2):86-9. PubMed ID: 25989920
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Economic evaluation approaches for new technology.
    Papatheofanis FJ
    IEEE Eng Med Biol Mag; 2003; 22(3):16-7. PubMed ID: 12845811
    [No Abstract]   [Full Text] [Related]  

  • 7. The economic evaluation of medical devices: challenges.
    Kingkaew P; Teerawattananon Y
    J Med Assoc Thai; 2014 May; 97 Suppl 5():S102-7. PubMed ID: 24964706
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Organisational impact: Definition and assessment methods for medical devices.
    Roussel C; Carbonneil C; Audry A;
    Therapie; 2016 Feb; 71(1):69-96. PubMed ID: 27080633
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A review of the economic tools for assessing new medical devices.
    Craig JA; Carr L; Hutton J; Glanville J; Iglesias CP; Sims AJ
    Appl Health Econ Health Policy; 2015 Feb; 13(1):15-27. PubMed ID: 25139635
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Review of Economic Submissions to NICE Medical Technologies Evaluation Programme.
    Alshreef A; Jenks M; Green W; Dixon S
    Appl Health Econ Health Policy; 2016 Dec; 14(6):623-634. PubMed ID: 27480537
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Investigating the Generalizability of Economic Evaluations Conducted in Italy: A Critical Review.
    Ruggeri M; Manca A; Coretti S; Codella P; Iacopino V; Romano F; Mascia D; Orlando V; Cicchetti A
    Value Health; 2015 Jul; 18(5):709-20. PubMed ID: 26297100
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Linking the Regulatory and Reimbursement Processes for Medical Devices: The Need for Integrated Assessments.
    Ciani O; Wilcher B; van Giessen A; Taylor RS
    Health Econ; 2017 Feb; 26 Suppl 1():13-29. PubMed ID: 28139087
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The economic evaluation of medical devices: challenges ahead.
    Kirisits A; Redekop WK
    Appl Health Econ Health Policy; 2013 Feb; 11(1):15-26. PubMed ID: 23329383
    [TBL] [Abstract][Full Text] [Related]  

  • 14. New decision-making processes for the pricing of health technologies in Japan: The FY 2016/2017 pilot phase for the introduction of economic evaluations.
    Shiroiwa T; Fukuda T; Ikeda S; Takura T
    Health Policy; 2017 Aug; 121(8):836-841. PubMed ID: 28687183
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Consolidated Health Economic Evaluation Reporting Standards (CHEERS)--explanation and elaboration: a report of the ISPOR Health Economic Evaluation Publication Guidelines Good Reporting Practices Task Force.
    Husereau D; Drummond M; Petrou S; Carswell C; Moher D; Greenberg D; Augustovski F; Briggs AH; Mauskopf J; Loder E;
    Value Health; 2013; 16(2):231-50. PubMed ID: 23538175
    [TBL] [Abstract][Full Text] [Related]  

  • 16. HTA of medical devices: Challenges and ideas for the future from a European perspective.
    Fuchs S; Olberg B; Panteli D; Perleth M; Busse R
    Health Policy; 2017 Mar; 121(3):215-229. PubMed ID: 27751533
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Addressing the need for economic evaluation of cardiovascular medical devices in India.
    Masurkar PP
    Curr Probl Cardiol; 2024 Aug; 49(8):102677. PubMed ID: 38795804
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Understanding cost effectiveness: money matters?
    Sprague S; Quigley L; Adili A; Bhandari M
    J Long Term Eff Med Implants; 2007; 17(2):145-52. PubMed ID: 18540857
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Adapting health technology assessment for drugs, medical devices, and health programs: Methodological considerations from the Indian experience.
    Prinja S; Jyani G; Gupta N; Rajsekar K
    Expert Rev Pharmacoecon Outcomes Res; 2021 Oct; 21(5):859-868. PubMed ID: 33882762
    [TBL] [Abstract][Full Text] [Related]  

  • 20. TAXONOMY OF MEDICAL DEVICES IN THE LOGIC OF HEALTH TECHNOLOGY ASSESSMENT.
    Henschke C; Panteli D; Perleth M; Busse R
    Int J Technol Assess Health Care; 2015 Jan; 31(5):324-30. PubMed ID: 26711471
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.